Terns Clinical Study Site 1039 — Los Angeles, California

Terns Clinical Study Site 1039 is a clinical research site located in Los Angeles, California, United States 90048.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Terns Clinical Study Site 1039 has participated in 1 clinical trials.

Therapeutic areas: NASH - Nonalcoholic Steatohepatitis.

Sponsors: Terns, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Terns Clinical Study Site 1039?

Terns Clinical Study Site 1039 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Terns Clinical Study Site 1039 conducted?

Terns Clinical Study Site 1039 has 1 clinical trials on record. Their work covers NASH - Nonalcoholic Steatohepatitis.

Is Terns Clinical Study Site 1039 accredited by Crixeo Health?

Terns Clinical Study Site 1039 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Terns Clinical Study Site 1039?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.